Gaviscon

Indigestion, Heartburn, Urinary Bladder + 4 more

Treatment

9 FDA approvals

20 Active Studies for Gaviscon

What is Gaviscon

Magnesium carbonate

The Generic name of this drug

Treatment Summary

Alginic acid, also known as algin or alginate, is a type of polysaccharide extracted from certain seaweed species. It forms a thick, viscous gel when mixed with water. Alginic acid is made up of molecules of L-glucuronic acid and D-mannuronic acid and is used in a variety of products, including food, cosmetics, and pharmaceuticals. It is approved by the FDA as an emulsifier, thickener, and stabilizer in soups and soup mixes. It is also found in antacids to help reduce gastric acid reflux, and

Inon

is the brand name

image of different drug pills on a surface

Gaviscon Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Inon

Magnesium carbonate

1989

2

Approved as Treatment by the FDA

Magnesium carbonate, also known as Inon, is approved by the FDA for 9 uses like Heartburn and Kidney Stones .

Heartburn

Kidney Stones

Used to treat Kidney Stones in combination with Citric acid

Indigestion

Irrigation

Used to treat catheter irrigation in combination with Citric acid

Irrigation

Used to treat catheter irrigation therapy in combination with Citric acid

Upset stomach

Kidney Stones

Used to treat Kidney Stones in combination with Citric acid

Heartburn

Urinary Bladder

Used to treat Calculus bladder in combination with Citric acid

Effectiveness

How Gaviscon Affects Patients

Alginic acid works to reduce stomach acid reflux by forming a physical barrier. This barrier, called a "raft", is formed when the acid meets the alginic acid, usually within a few seconds of taking it. In clinical trials, alginic acid has been shown to reduce GERD symptoms. It has also been shown to reduce postprandial reflux when taken with an antacid. Alginic acid binds to cations when consumed.

How Gaviscon works in the body

When swallowed, alginic acid reacts with stomach acid to create a foam-like barrier on the surface of the stomach contents. This barrier helps prevent stomach acid from refluxing back up into the esophagus, which can reduce pain and discomfort. In severe cases, the foam itself can be refluxed, providing a soothing effect.

When to interrupt dosage

The measure of Gaviscon is contingent upon the diagnosed condition, including Hiatus Hernia, Dyspepsia and Gastroesophageal Reflux Disease (GERD). The dosage can be found in the table below, contingent on the approach to delivery.

Condition

Dosage

Administration

Kidney Stones

, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg

Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Powder, Capsule, Granule - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Irrigation, Solution, Solution - Irrigation, Granule, effervescent, Granule, Granule, effervescent - Oral

Irrigation

, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg

Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Powder, Capsule, Granule - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Irrigation, Solution, Solution - Irrigation, Granule, effervescent, Granule, Granule, effervescent - Oral

Irrigation

, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg

Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Powder, Capsule, Granule - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Irrigation, Solution, Solution - Irrigation, Granule, effervescent, Granule, Granule, effervescent - Oral

Heartburn

, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg

Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Powder, Capsule, Granule - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Irrigation, Solution, Solution - Irrigation, Granule, effervescent, Granule, Granule, effervescent - Oral

Indigestion

, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg

Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Powder, Capsule, Granule - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Irrigation, Solution, Solution - Irrigation, Granule, effervescent, Granule, Granule, effervescent - Oral

Urinary Bladder

, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg

Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Powder, Capsule, Granule - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Irrigation, Solution, Solution - Irrigation, Granule, effervescent, Granule, Granule, effervescent - Oral

Upset stomach

, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg

Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Powder, Capsule, Granule - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet - Oral, Tablet, Irrigation, Solution, Solution - Irrigation, Granule, effervescent, Granule, Granule, effervescent - Oral

Warnings

Gaviscon Contraindications

Condition

Risk Level

Notes

Urinary Tract Infections

Do Not Combine

urinary tract extravasation

Do Not Combine

There are 20 known major drug interactions with Gaviscon.

Common Gaviscon Drug Interactions

Drug Name

Risk Level

Description

2,5-Dimethoxy-4-ethylamphetamine

Major

The serum concentration of 2,5-Dimethoxy-4-ethylamphetamine can be increased when it is combined with Magnesium carbonate.

2,5-Dimethoxy-4-ethylthioamphetamine

Major

The serum concentration of 2,5-Dimethoxy-4-ethylthioamphetamine can be increased when it is combined with Magnesium carbonate.

4-Bromo-2,5-dimethoxyamphetamine

Major

The serum concentration of 4-Bromo-2,5-dimethoxyamphetamine can be increased when it is combined with Magnesium carbonate.

Amphetamine/Dextroamphetamine

Major

The serum concentration of Amphetamine can be increased when it is combined with Magnesium carbonate.

Atazanavir

Major

Magnesium carbonate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.

Gaviscon Toxicity & Overdose Risk

Taking more than 15g/kg of this drug can be lethal for humans. Symptoms of overdosing on this drug may include abdominal bloating, intestinal blockage, nausea, vomiting, and difficulty swallowing. Inhaling or swallowing this drug can cause lung inflammation. If someone has overdosed on this drug, they should receive medical treatment.

image of a doctor in a lab doing drug, clinical research

Gaviscon Novel Uses: Which Conditions Have a Clinical Trial Featuring Gaviscon?

88 active studies are looking into the possibility of utilizing Gaviscon for Flatulence, Hiatus Hernia and Reflux Esophagitis (RE) treatment.

Condition

Clinical Trials

Trial Phases

Irrigation

0 Actively Recruiting

Upset stomach

0 Actively Recruiting

Urinary Bladder

0 Actively Recruiting

Kidney Stones

34 Actively Recruiting

Early Phase 1, Not Applicable, Phase 2, Phase 1

Indigestion

6 Actively Recruiting

Phase 3, Phase 2, Not Applicable, Phase 4

Irrigation

0 Actively Recruiting

Heartburn

3 Actively Recruiting

Phase 3, Not Applicable

Gaviscon Reviews: What are patients saying about Gaviscon?

5

Patient Review

7/26/2022

Gaviscon for Condition in which Stomach Acid is Pushed Into the Esophagus

I love this medicine, it's a life saver. I've been using it since it was released at 80 rs, but now the company has become so greedy and increased prices every few months... Now the price is increased again to 164 rs. Stop being greedy!

5

Patient Review

8/16/2022

Gaviscon for Stomach Ulcer

This has been an extremely effective way for me to control my stomach acid. I was initially hesitant because it's available over-the-counter, but this really does work well.

5

Patient Review

2/28/2022

Gaviscon for Condition in which Stomach Acid is Pushed Into the Esophagus

This treatment is really effective and it only took 2-3 minutes to start working.

5

Patient Review

5/31/2017

Gaviscon for Heartburn

I was diagnosed with GERD/Acid Reflux in 2010 and prescribed Pantoloc 40mg. This medication did not work for me; I would cough all night and have to sleep upright for 1-3 hours before finally falling asleep. In early 2016, a good EENT doctor recommended Gaviscon Extra and it has controlled my acid reflux 100%. I am so grateful and thankful to that doctor!

5

Patient Review

1/7/2017

Gaviscon for Hiatal Hernia with Esophagus Inflammation from Acid Reflux

I've been using Gaviscon for three months to treat my gastritis, and it's been working great in conjunction with an acid inhibitor. However, I recently noticed that my silver necklace has started tarnishing. Could the medication be causing this?

5

Patient Review

4/16/2015

Gaviscon for Ulcer from Stomach Acid

It is effective. I'm wondering if I should take it before or after my cardiac medication, though.

5

Patient Review

12/4/2021

Gaviscon for Conditions of Excess Stomach Acid Secretion

I've been struggling with some intense acid reflux as of late. Thankfully, my doctor recommended Gaviscon to help ease the pain. And it really does work wonders! I noticed a difference within just three or four minutes after taking it.

5

Patient Review

9/6/2022

Gaviscon for Heartburn

These heartburn relief tablets work almost instantaneously, which always shocks me. They're definitely a lifesaver.

5

Patient Review

3/25/2014

Gaviscon for Hiatal Hernia with Esophagus Inflammation from Acid Reflux

5

Patient Review

4/19/2014

Gaviscon for Conditions of Excess Stomach Acid Secretion

5

Patient Review

8/31/2022

Gaviscon for Indigestion

I don't think a more effective drug exists anywhere. It gave me instant relief.

4.7

Patient Review

6/22/2020

Gaviscon for Conditions of Excess Stomach Acid Secretion

I use this product whenever I'm bloated, and it works like a charm every single time.

4.3

Patient Review

2/20/2022

Gaviscon for Heartburn

This medication is really effective for me, and I only need a small amount. It numbs my mouth and cools everything down, which is a huge relief when I'm dealing with bad heartburn.

4

Patient Review

5/17/2020

Gaviscon for Heartburn

Gavison is great for when I get heartburn. It's quickly relieved me about 90% of the time, and within 15 minutes at that! If I'm still in pain after half an hour, I'll take another 1/2 tablet. As a side note, East Indian cuisine really gives me some bad acid reflux!

3.3

Patient Review

5/27/2014

Gaviscon for Stomach Ulcer

This drug is good, but you have to take it every day. I had breathing problems and pain at night due to acid in my esophagus, but now that I'm taking this medication regularly, those symptoms have gone away.

1

Patient Review

6/10/2022

Gaviscon for Hiatal Hernia with Esophagus Inflammation from Acid Reflux

This treatment did not improve my symptoms and, if anything, made them worse.

1

Patient Review

9/12/2022

Gaviscon for Heartburn

Gaviscon infant is prescribed for children under the age of four, so this review is irrelevant.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about gaviscon

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Gaviscon safer than omeprazole?

"There was no significant difference between groups in pain intensity reduction, although overall qualitative pain relief was slightly (p = 0.049) in favor of omeprazole. Results of the GOOD trial also showed that Gaviscon and omeprazole 20 mg could be used both safely."

Answered by AI

What is Gaviscon used for?

"Gaviscon can be used to treat heartburn (acid reflux) and indigestion by forming a protective layer that floats on top of the contents of your stomach and stops stomach acid from escaping into your food pipe."

Answered by AI

Should you drink water with Gaviscon?

"You should chew the chewable tablets thoroughly before swallowing, and then drink a full glass of water. If you are using the liquid form of this medication, shake the bottle well before each dose, and refrigerate it to improve the flavor. Do not freeze."

Answered by AI

Is Gaviscon the best antacid?

"Gaviscon Double Action Liquid was more effective than an antacid without alginate in reducing stomach acid exposure after a meal. However, the number and distribution of reflux events within the esophagus were similar."

Answered by AI

Clinical Trials for Gaviscon

Image of Sault Area Hospital in Sault Ste. Marie, Canada.

Mini-Flexible Ureteroscopy for Kidney Stones

18+
All Sexes
Sault Ste. Marie, Canada

This prospective, randomized, single-blinded, non-inferiority clinical trial will compare the clinical outcomes and cost-effectiveness of two mini-flexible ureteroscopes (6.3Fr and 7.5Fr) used during flexible ureteroscopy for the treatment of renal stones. Adult patients with renal stones up to 15 mm who are scheduled to undergo flexible ureteroscopy will be randomly assigned to one of the two study groups. The primary objectives are to compare stone-free rates and the ability to achieve primary renal access without preoperative ureteral stenting. Secondary outcomes include operative time, fluoroscopy use, ureteral trauma, postoperative stenting, pain, complications, emergency department visits, need for additional procedures, hospital stay, and cost-effectiveness. The results of this study are expected to provide high-quality evidence to guide the selection of mini-flexible ureteroscopes and improve the quality, safety, and value of surgical care for patients with kidney stones.

Waitlist Available
Has No Placebo

Sault Area Hospital

Yasser A Noureldin, MD, PhD

Image of Ohio State University Wexner Medical Center in Columbus, United States.

Virtual Poetry Workshops for Anxiety

18+
All Sexes
Columbus, OH

This study examines whether participating in poetry workshops can improve emotional well-being among patients with chronic digestive symptoms. Many individuals with long-standing digestive conditions experience distress, anxiety, isolation, and difficulty expressing their emotions in clinical settings. These emotional challenges can negatively affect daily life, relationships, and overall health. Poetry writing offers a creative and supportive way for participants to explore their feelings, express their experiences, and build emotional resilience. It also allows individuals to focus on aspects of their identity beyond their illness. The purpose of this research is to evaluate whether poetry workshops can reduce anxiety, lessen feelings of isolation, and strengthen participants' sense of community and well being. 1\. Why is this study being done? The purpose of this research study is to offer a creative outlet for patients to explore their identity and story, build resilience, and seek hope. This study is being done because we understand that the psychological discomfort that can come upon hearing a diagnosis can lead to increased anxiety levels, negatively impacting a patient's well-being and relationships. Often healthcare practitioners may merely view a patient through the lens of their diagnosis, neglecting other aspects of their identity and humanity. Through reading various poems, crafting their own poems, and sharing their work with their peers, we hope the workshops offer a comforting opportunity for the participants to explore their identities and creativity.

Recruiting
Has No Placebo

Ohio State University Wexner Medical Center

Subhankar CHAKRABORTY, MD, Ph.D.

Have you considered Gaviscon clinical trials?

We made a collection of clinical trials featuring Gaviscon, we think they might fit your search criteria.
Go to Trials
Image of Cleveland Clinic in Cleveland, United States.

Antireflux Surgery for Acid Reflux

18+
All Sexes
Cleveland, OH

The goal of this clinical trial is to learn if people can safely skip a test called esophageal manometry before surgery for acid reflux (gastroesophageal reflux disease, or GERD) or a hiatal hernia. Manometry measures the muscles of the food pipe using a thin tube passed through the nose. The test can be uncomfortable and can delay surgery. The main questions this study aims to answer are whether people can skip manometry and still have good swallowing one year after surgery, and whether skipping the test lowers discomfort, shortens the wait for surgery, and lowers cost. To answer this, researchers will compare two groups. One group will have surgery without manometry. The other group will have manometry first, the way it is usually done. Everyone will get the same operation, a partial wrap called a Toupet fundoplication, so the study tests the value of the test and not the surgery. Participants will be placed by chance into one of the two groups, have the same standard operation, and fill out short questionnaires about their swallowing before surgery and again at 3, 6, and 12 months after surgery. Researchers want to find out if skipping manometry works just as well as the usual approach for people who do not have trouble swallowing before surgery.

Waitlist Available
Has No Placebo

Cleveland Clinic (+1 Sites)

Image of Mayo Clinic Arizona in Phoenix, United States.

Laser Treatments for Kidney Stones

18+
All Sexes
Phoenix, AZ

The purpose of this study is to compare two laser technologies that are routinely used during ureteroscopy for the treatment of kidney stones. Specifically, this study will compare a pulsed Thulium:YAG laser to a pulse-modulated Holmium:YAG laser (Moses technology) to evaluate how effective and safe they are when used to break kidney stones. Primary endpoints include stone-free rate and the zero stone-free rate at a standardized postoperative. Secondary endpoints include total operative time, lasing time (s), laser energy expended (J), efficiency (laser energy expended/stone volume; stone volume/lasing time). These endpoints aim to provide a comprehensive assessment of the clinical effectiveness and procedural efficiency of the two laser systems.

Waitlist Available
Has No Placebo

Mayo Clinic Arizona (+1 Sites)

Esteban Emiliani, MD, PhD

Have you considered Gaviscon clinical trials?

We made a collection of clinical trials featuring Gaviscon, we think they might fit your search criteria.
Go to Trials
Image of United States, Alabama University of Alabama at Birmingham in Birmingham, United States.

Oxalate Synthesis for Kidney Stones

18 - 80
All Sexes
Birmingham, AL

The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will ingest fixed diets containing low amounts of oxalate for 5 days ingest a soluble form of glycolate and vitamin C collect urine, blood, stool during the dietary and oral dosing portions of the study and also collect breath sample during the oral glycolate test

Recruiting
Has No Placebo

United States, Alabama University of Alabama at Birmingham (+1 Sites)

Sonia Fargue, PhD

Image of University of Iowa in Iowa City, United States.

Genetic Testing for Kidney Stones

18 - 90
All Sexes
Iowa City, IA

Kidney stones continue to affect more and more people in the United States with the most recent estimate being 1 in 9 people will develop a stone in their life. While family history is a known risk factor for stone disease, it remains unclear whether this is related to learned dietary habits or a truly inheritable genetic condition. Known inheritable genetic conditions linked to stone formation are uncommon, and thus, routine genetic testing is not currently recommended by any major urologic organizations. Patients who form calcium phosphate predominant stones, a less common type of stone composition, tend to have alkaline urine pH which suggests that the kidneys are unable to rid the body of acid. Management of such patients for stone prevention can be difficult. The Iowa Institute for Human Genomics is one of only a handful of commercial labs which offers genetic testing for stone disease. The aim of this study is to assess the rate of genetic abnormalities amongst calcium phosphate predominant stone formers with alkaline urine. To this end, the investigators plan to enroll calcium phosphate predominant stone forming patients with alkaline urine on 24 hour urine collection who obtain their health care at UIHC to undergo free genetic testing via blood draw to assess for genetic abnormalities. The investigators will also collect information already available in the subject's chart to assess for other patterns between blood and urine tests and any genetic variants.

Recruiting
Has No Placebo

University of Iowa

Have you considered Gaviscon clinical trials?

We made a collection of clinical trials featuring Gaviscon, we think they might fit your search criteria.
Go to Trials